Edgestream Partners L.P. Invests $2.43 Million in STERIS plc (NYSE:STE)

Edgestream Partners L.P. bought a new position in shares of STERIS plc (NYSE:STE) during the 4th quarter, Holdings Channel reports. The institutional investor bought 11,804 shares of the medical equipment provider’s stock, valued at approximately $2,426,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Ashton Thomas Securities LLC acquired a new position in STERIS during the third quarter worth approximately $25,000. Human Investing LLC acquired a new position in STERIS during the fourth quarter worth approximately $31,000. Anfield Capital Management LLC increased its position in STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 91 shares during the period. Central Pacific Bank Trust Division increased its position in STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 76 shares during the period. Finally, Manchester Capital Management LLC increased its position in STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 137 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Trading Up 0.3 %

Shares of STE stock opened at $233.02 on Monday. The business’s 50 day moving average is $216.96 and its two-hundred day moving average is $222.70. STERIS plc has a twelve month low of $197.82 and a twelve month high of $248.24. The company has a market capitalization of $22.89 billion, a P/E ratio of 49.47 and a beta of 0.92. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Equities analysts forecast that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be paid a $0.57 dividend. The ex-dividend date is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 0.98%. STERIS’s dividend payout ratio (DPR) is presently 48.41%.

Analyst Ratings Changes

Several research analysts have commented on the company. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research report on Thursday, February 6th. Stephens reaffirmed an “overweight” rating and set a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. Finally, Piper Sandler lifted their target price on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.